{
    "clinical_study": {
        "@rank": "10074", 
        "arm_group": [
            {
                "arm_group_label": "Sepsis", 
                "description": "Sepsis Forty eight patients developed septic complication during ICU stay (sepsis group)."
            }, 
            {
                "arm_group_label": "SIRS group", 
                "description": "SIRS group Forty seven patients were critically ill without evidence of infectious organism (SIRS group)."
            }
        ], 
        "brief_summary": {
            "textblock": "A total of ninety - five patients (54men and 41women) were included in the study.\n      Fifty-eight patients developed septic complication during ICU stay (sepsis group). Forty\n      seven patients were critically ill without evidence of infectious organism (SIRS group). At\n      admission, Patients data include clinical status; SOFA score; central venous pressure;\n      laboratory analysis and arterial blood gas analysis were measured. Routine cultures were\n      obtained. The attending physician evaluated the patients for sepsis, severe sepsis, or\n      septic shock as long as their stay in ICU. Memory B cells and Heinz bodies  were  monitored."
        }, 
        "brief_title": "The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Sepsis", 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Sepsis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The patients staying in ICU for more than 24 hours were enrolled in the study. Patients\n      received anti-inflammatory drugs or corticosteroids before admission, patients had\n      immunosuppressive illness, patients had chronic organ failure; patients received massive\n      blood transfusion; patients with radiation therapy and patients with previous organ\n      transplantation were excluded from the study. At admission, patient's age, sex, weight and\n      height were recorded. Patients data that include the clinical status; sequential organ\n      failure assessment (SOFA) score; temperature; heart rate; respiratory rate; blood pressure;\n      central venous pressure; laboratory analysis (complete blood count, blood urea nitrogen,\n      blood sugar, serum sodium, potassium, calcium, aspartate aminotransferase, alanine\n      aminotransferase, prothrombin time, albumin and CRP) and arterial blood gas analysis were\n      measured. Routine cultures of suspected sites, blood and urine were obtained to determine\n      the presence of infection. We attempted to maintain the patient hemoglobin level at\n      10-12g/dl and central venous pressure at 8-12 cmH2o. When needed, intravascular fluid\n      replacement, blood products and inotropic or vasopressor agents were administered. Each day\n      the attending physician evaluated all the study patients for sepsis, severe sepsis, or\n      septic shock as long as their stay in ICU."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Critically ill patients with manifestation of sepsis or SIRS\n\n        Exclusion Criteria:\n\n          -  Patients received anti-inflammatory drugs or corticosteroids before admission, who\n             had immunosuppressive illness, who had chronic organ failure; who had received\n             massive blood transfusion; those with radiation therapy, previous organ\n             transplantation were excluded from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "A total of ninety five patients  were included in the study. fifty eight patients\n        developed septic complication during ICU stay (sepsis group). fifty seven patients were\n        critically ill without evidence of infectious organism (SIRS group). At admission, the\n        patient's age, sex, height and weight were recorded."
            }
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02108405", 
            "org_study_id": "1020/02/13"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "critically ill patient.", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tanta", 
                    "country": "Egypt", 
                    "state": "Algharbyia", 
                    "zip": "35217"
                }, 
                "name": "Tanta University"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients", 
        "overall_official": {
            "affiliation": "Assistant Professor", 
            "last_name": "Ayman A Yousef, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Memory B cells detection was made using flowcytometry.", 
            "measure": "Memory B cells", 
            "safety_issue": "Yes", 
            "time_frame": "1 day (At time of ICU  admission)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02108405"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tanta University", 
            "investigator_full_name": "Ayman Abd Al-maksoud Yousef", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Heinz bodies using flow cytometry", 
            "measure": "Heinz bodies", 
            "safety_issue": "Yes", 
            "time_frame": "1 day (At ICU admission)"
        }, 
        "source": "Tanta University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tanta University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}